Lightnews — Scholar-powered news

Lucie Berkovitch @lucieberko.bsky.social · 26d

Thank you so much @haunted.audio, it is an amazing series!

Lucie Berkovitch @lucieberko.bsky.social · 26d

This amazing series by Tim Hayward and Richard Ward @haunted.audio (🙏🙏🙏) also featured renowned neuroscientists such as @christimmermann.bsky.social, @katrinpreller.bsky.social, Gul Dölen, as well as nurses, historians, philosophers, sociologists, etc.

Enjoy! 🎧

2 2

Lucie Berkovitch @lucieberko.bsky.social · 26d

In the first episode, I explain what is specific about psychedelics as treatment in psychiatry.
In last episode, dealing about the future of psychedelics, I talk about the possible dissociation between the psychedelic experience and the therapeutic effects:

www.bbc.co.uk/programmes/m...

BBC Radio 4 - Understand, The Trip, 10. Unknown unknowns

What more is there to learn about psychedelics? Tim Hayward makes a case for curiosity.

www.bbc.co.uk

1 1 2

Lucie Berkovitch @lucieberko.bsky.social · 26d

🎙️ I am very proud to have participated (with a very strong French accent) to the BBC Radio 4 program Understand entitled "The Trip", about the science, culture, history and future of psychedelics 🌈

www.bbc.co.uk/programmes/m...

1 3 5

Reposted by Lucie Berkovitch

Mediterranean Society for Consciousness Science @mesec-community.bsky.social · Sep 4

A few moments from our ongoing MESEC 2025 Workshop (‘Centering Experience in Mental Health: Uniting Psychiatry and Consciousness Science’) at the beautiful Lago di Bolsena!

@lucieberko.bsky.social
@tehseennoorani.bsky.social

3 11

Reposted by Lucie Berkovitch

Editors of Neuroscience of Consciousness @nconsc.bsky.social · Aug 26

🚨 New article in #NCONSC

Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia
academic.oup.com/nc/article/2...

@lucieberko.bsky.social

#consciousness
🧠🧪

Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia

Abstract. Disruption of conscious access contributes to the advent of psychotic symptoms in schizophrenia and could also explain lack of insight in other p

academic.oup.com

3 3

Lucie Berkovitch @lucieberko.bsky.social · Sep 3

🙏 A huge thanks to my co-authors Selim Tümkaya, Bengü Yücens, Mohamed Gunduz and Maxime Maheu @maheump.bsky.social

2

Lucie Berkovitch @lucieberko.bsky.social · Sep 3

In sum :
✅ Consciousness disruption translates into various symptomatic expressions according to the psychiatric disorder
✅ In patients with OCD, consciousness disruption delineates two distinct subgroups in terms of cognitive deficits and clinical features

1 3

Lucie Berkovitch @lucieberko.bsky.social · Sep 3

‼️ Patients with SCZ have consciousness disruption in relation with positive symptoms
‼️ Patients with OCD who have a poor insight exhibit similar consciousness deficits as patients with schizophrenia
‼️ Patients with OCD and good insight performed similarly to controls ⤵️

1 1

Lucie Berkovitch @lucieberko.bsky.social · Sep 3

We compared consciousness measures in patients with #OCD and with #schizophrenia as a function of symptom relevant dimensions.

😮 We found pretty surprising results: ⤵️

1 1

Lucie Berkovitch @lucieberko.bsky.social · Sep 3

🗞️ First article as #lastauthor published in Neuroscience of Consciousness @nconsc.bsky.social 🥳 🥳 🥳

academic.oup.com/nc/article/d...

🔍 In this study, we examine how #consciousness disruption translates into clinical manifestations in different #psychiatric disorders. 🧶⤵️

Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia

Abstract. Disruption of conscious access contributes to the advent of psychotic symptoms in schizophrenia and could also explain lack of insight in other p

academic.oup.com

3 4 11

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

Berko on air de bon matin sur @franceculture.fr

www.radiofrance.fr/francecultur...

Les substances hallucinogènes peuvent-elles soigner l’alcoolisme et la dépression ?

La dépendance à l’alcool serait, selon le ministère de la Santé, responsable chaque année de 49 000 décès. Mais selon une étude menée par le CHU de de Nîmes, les champignons hallucinogènes pourraient ...

www.radiofrance.fr

1 2

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

Thanks to all my collaborators!!

1

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

Overall, our results underscore that a univariate data-driven symptom improvement measure can be more sensitive to detect antidepressant action and is specifically associated with baseline neurobehavioral features.

1 1

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

Moreover, improvement was more robustly predicted by baseline neural and clinical features under antidepressant compared to placebo.

1 1

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

However, the intensity of antidepressant and placebo response significantly differs (in previous papers on this dataset, scale level measures of improvement could not distinguish between the two).

1 1

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

We applied principal component analysis (PCA) on the variations of items from multiple clinical scales and strikingly observed a similar pattern of clinical improvement across antidepressant and placebo arms.

1 2

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

We explored clinical response in patients with major depressive disorder from the EMBARC dataset.

1 1

Lucie Berkovitch @lucieberko.bsky.social · Aug 16

New paper out in Psychological Medicine where we found that #sertraline and #placebo strikingly induce a similar clinical improvement predicted by distinct neural configurations!

doi.org/10.1017/S003...

A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns | Psychological Medicine | Cambridge Core

A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns - Volume 55

doi.org

1 1 4

Lucie Berkovitch @lucieberko.bsky.social · Jun 8

A big thank to my colleagues Baptiste Fauvel, @katrinpreller.bsky.social and Raphaël Gaillard

Please find here the link for free access until 27th of July:
authors.elsevier.com/a/1lE1NY3M3l...

Enjoy!!

authors.elsevier.com

5

Lucie Berkovitch @lucieberko.bsky.social · Jun 8

🧠 No fewer than 81 articles are described in depth and put together to provide an overview of the neurocognitive effects of psilocybin in healthy volunteers and people with medical conditions.

😅 Believe me, it was quite a long journey before it was published in Neuroscience & Biobehavioral Reviews!

1 3

Lucie Berkovitch @lucieberko.bsky.social · Jun 8

📚 Just another #review about #psychedelics? Maybe... but in this paper we systematically reviewed ALL neuroimaging articles involving #psilocybin intake in humans.
www.sciencedirect.com/science/arti...

Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans

Psilocybin is a psychedelic serotonergic compound that is renowned for its potent psychoactive effects. Over the past 15 years, an increasing number o…

www.sciencedirect.com

1 6 21

Lucie Berkovitch @lucieberko.bsky.social · Jun 6

Please feel free to join the AFPBN Psychedelic Medicine Section via our website: www.afpbn.org/sections/med...

Médecine Psychédélique - AFPBN

www.afpbn.org

Lucie Berkovitch @lucieberko.bsky.social · Jun 6

💯 The event was SOLD OUT, highlighting that psychedelic medicine is a hot topic in France.

My colleagues of the section (Luc Mallet, Bruno Romeo, Hugo Bottemanne) and I worked hard, and we are very proud that this event was such a hit 🌈

1

Lucie Berkovitch @lucieberko.bsky.social · Jun 6

🙏 Thanks also to the MILDECA for their support, Com' To Evidence for the organization, and all the section members who chaired the talks: Baptiste Fauvel, Anne Claret, Alexandre Alt, Laetitia Vanderijst, Jerome Jeanblanc, @marcgielen.bsky.social, Carine Becamel, Michael Koslowski, Alain Gardier.

1